Mona Shehata is an Associate Principal Scientist at AstraZeneca, where they specialize in obesity-driven female hormonal cancers, particularly focusing on breast and endometrial cancers. They hold a PhD in Oncology and Cancer Biology from the University of Sydney and have previously served as a Group Leader at the University of Cambridge and a Postdoctoral Researcher at the Cancer Research UK Cambridge Institute. Mona's research employs stem cell technologies and genomics to develop biomarkers aimed at improving early detection and personalized treatments for at-risk patients. Their work is dedicated to translating scientific findings into tangible patient benefits.
This person is not in the org chart
This person is not in any teams
This person is not in any offices